Compare BKU & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BKU | TMDX |
|---|---|---|
| Founded | 2009 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.4B |
| IPO Year | 2010 | 2019 |
| Metric | BKU | TMDX |
|---|---|---|
| Price | $46.70 | $113.02 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 9 |
| Target Price | $52.25 | ★ $148.22 |
| AVG Volume (30 Days) | 778.3K | ★ 951.8K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.83% | N/A |
| EPS Growth | 14.61 | ★ 382.18 |
| EPS | 3.53 | ★ 4.87 |
| Revenue | $21,732,000.00 | ★ $605,494,000.00 |
| Revenue This Year | $16.46 | $24.51 |
| Revenue Next Year | $4.77 | $18.72 |
| P/E Ratio | ★ $13.23 | $23.37 |
| Revenue Growth | 7.45 | ★ 37.13 |
| 52 Week Low | $30.03 | $82.62 |
| 52 Week High | $52.11 | $156.00 |
| Indicator | BKU | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 56.84 | 48.57 |
| Support Level | $44.00 | $109.43 |
| Resistance Level | $52.04 | $131.86 |
| Average True Range (ATR) | 1.17 | 5.39 |
| MACD | 0.43 | 1.73 |
| Stochastic Oscillator | 75.62 | 78.08 |
BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses. The company also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products including commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.